Basal Cell Carcinoma: An Evidence-Based Treatment Update

被引:79
作者
Clark, Charlotte M. [1 ]
Furniss, Megan [1 ]
Mackay-Wiggan, Julian M. [1 ]
机构
[1] Columbia Univ, Dept Dermatol, Med Ctr, New York, NY 10032 USA
关键词
IMIQUIMOD 5-PERCENT CREAM; AMINOLEVULINATE PHOTODYNAMIC THERAPY; MOHS MICROGRAPHIC SURGERY; 5-YEAR FOLLOW-UP; METHYL AMINOLEVULINATE; SURGICAL EXCISION; SIGNIFICANTLY IMPROVES; TOPICAL IMIQUIMOD; RECURRENCE RATE; PHASE-III;
D O I
10.1007/s40257-014-0070-z
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Basal cell carcinoma (BCC) is the most common skin cancer. Surgical excision remains the standard of treatment, but several alternative treatment modalities exist. Objectives This review aims to provide a current analysis of evidence for the treatment of BCC; specifically, which treatments have the lowest recurrence rates and the best cosmetic outcomes. Methods We searched PubMed (January 1946 to August 2013), Ovid MEDLINE (2003-August 2013), the Cochrane Central Register of Controlled Trials (January 1993 to August 2013), and the Cochrane Database of Systematic Reviews (The Cochrane Library Issue 9, 2013) databases for randomized controlled trials, systematic reviews, or comparative studies for the treatment of BCC. Results We found 615 potential articles. Two independent reviewers selected 40 studies: 29 randomized controlled trials (RCTs), seven systematic reviews, and four nonrandomized prospective trials. Treatment modalities reviewed include surgical therapy, radiotherapy and cryotherapy, photodynamic therapy (PDT), topical imiquimod, topical 5-fluorouracil (5-FU), topical solasodine glycoalkaloids, topical ingenol mebutate, intralesional 5-FU, intralesional interferon (IFN), and oral hedgehog pathway inhibitors. Conclusions The available data suggest that surgical methods remain the gold standard in BCC treatment, with Mohs micrographic surgery typically utilized for high-risk lesions. Suitable alternate treatment options for appropriately selected primary low-risk lesions may include PDT, cryotherapy, topical imiquimod, and 5-FU. Radiotherapy is a suitable alternate for surgical methods for treatment in older patient populations. Electrodesiccation and curettage (ED&C) is a commonly used primary treatment option for low-risk lesions; however, there were no RCTs examining ED&C that met our inclusion criteria. New hedgehog pathway inhibitors are promising for the management of advanced BCC; however, side effects are a concern for some patients, and much remains to be learned regarding optimal treatment length, risk of recurrence, and potential development of resistance. There is insufficient evidence at present to make recommendations on topical solasodine glycoalkaloids, topical ingenol mebutate, and intralesional 5-FU and IFN-alpha. Overall continued research on the efficacy of treatment modalities is needed. In particular, studies should include histologic ascertainment of clearance, long-term follow-up, stratification based on tumor subtype, and comparison with surgical outcomes.
引用
收藏
页码:197 / 216
页数:20
相关论文
共 48 条
[1]   Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma [J].
不详 .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (10) :1393-1396
[2]  
[Anonymous], BASAL CELL SQUAMOUS
[3]  
[Anonymous], CLIN EVID
[4]  
[Anonymous], BASAL CELL CARCINOMA
[5]   Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial [J].
Arits, Aimee H. M. M. ;
Mosterd, Klara ;
Essers, Brigitte A. B. ;
Spoorenberg, Eefje ;
Sommer, Anja ;
De Rooij, Michette J. M. ;
van Pelt, Han P. A. ;
Quaedvlieg, Patricia J. F. ;
Krekels, Gertruud A. M. ;
van Neer, Pierre A. F. A. ;
Rijzewijk, Joris J. ;
van Geest, Adrienne J. ;
Steijlen, Peter M. ;
Nelemans, Patty J. ;
Kelleners-Smeets, Nicole W. J. .
LANCET ONCOLOGY, 2013, 14 (07) :647-654
[6]   Basal cell carcinoma of the face: Surgery or radiotherapy? Results of a randomized study [J].
Avril, MF ;
Auperin, A ;
Margulis, A ;
Gerbaulet, A ;
Duvillard, P ;
Benhamou, E ;
Guillaume, JC ;
Chalon, R ;
Petit, JY ;
SanchoGarnier, H ;
Prade, M ;
Bouzy, J ;
Chassagne, D .
BRITISH JOURNAL OF CANCER, 1997, 76 (01) :100-106
[7]   Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma:: a 5 year randomized trial [J].
Basset-Seguin, Nicole ;
Ibbotson, Sally H. ;
Emtestam, Lennart ;
Tarstedt, Mikael ;
Morton, Colin ;
Maroti, Marianne ;
Calzavara-Pinton, Piergiacomo ;
Varma, Sandeep ;
Roelandts, Rik ;
Wolf, Peter .
EUROPEAN JOURNAL OF DERMATOLOGY, 2008, 18 (05) :547-553
[8]   Interventions for basal cell carcinoma of the skin [J].
Bath-Hextall, F. J. ;
Perkins, W. ;
Bong, J. ;
Williams, H. C. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01)
[9]   AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: A report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery [J].
Connolly, Suzanne M. ;
Baker, Diane R. ;
Coldiron, Brett M. ;
Fazio, Michael J. ;
Storrs, Paul A. ;
Vidimos, Allison T. ;
Zalla, Mark J. ;
Brewer, Jerry D. ;
Begolka, Wendy Smith ;
Berger, Timothy G. ;
Bigby, Michael ;
Bolognia, Jean L. ;
Brodland, David G. ;
Collins, Scott ;
Cronin, Terrence A., Jr. ;
Dahl, Mark V. ;
Grant-Kels, Jane M. ;
Hanke, C. William ;
Hruza, George J. ;
James, William D. ;
Lober, Clifford Warren ;
McBurney, Elizabeth I. ;
Norton, Scott A. ;
Roenigk, Randall K. ;
Wheeland, Ronald G. ;
Wisco, Oliver J. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (04) :531-550
[10]   INTRALESIONAL INTERFERON THERAPY FOR BASAL-CELL CARCINOMA [J].
CORNELL, RC ;
GREENWAY, HT ;
TUCKER, SB ;
EDWARDS, L ;
ASHWORTH, S ;
VANCE, JC ;
TANNER, DJ ;
TAYLOR, EL ;
SMILES, KA ;
PEETS, EA .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 23 (04) :694-700